Invention Grant
- Patent Title: Dihydropyrrolopyridine inhibitors of RORγ
-
Application No.: US15709903Application Date: 2017-09-20
-
Publication No.: US10087184B2Publication Date: 2018-10-02
- Inventor: David A. Claremon , Lawrence Wayne Dillard , Chengguo Dong , Yi Fan , Lanqi Jia , Stephen D. Lotesta , Andrew Marcus , Suresh B. Singh , Colin M. Tice , Jing Yuan , Wei Zhao , Yajun Zheng , Linghang Zhuang
- Applicant: Vitae Pharmaceuticals, Inc.
- Applicant Address: US NJ Madison
- Assignee: Vitae Pharmaceuticals, Inc.
- Current Assignee: Vitae Pharmaceuticals, Inc.
- Current Assignee Address: US NJ Madison
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Michael J. DeGrazia
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K31/4353 ; C07D471/04
Abstract:
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
Public/Granted literature
- US20180222902A1 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA Public/Granted day:2018-08-09
Information query
IPC分类:
